# NILOTINIB HYDROCHLORIDE
> **ANDA219134** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2026-06-26
## Drug
- **FDA Application Number:** ANDA219134
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NILOTINIB HYDROCHLORIDE
- **Generic name:** Nilotinib Hydrochloride
- **Active ingredients:** NILOTINIB HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **First approval:** 2026-06-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219134)
---
*MORVS · CC0 1.0*